SEI Investments’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $883K | Buy |
93,726
+34,540
| +58% | +$379K | ﹤0.01% | 2409 |
|
|
2025
Q4 | $735K | Buy |
59,186
+32,515
| +122% | +$432K | ﹤0.01% | 2323 |
|
|
2025
Q3 | $382K | Buy |
26,671
+2,491
| +10% | +$34.1K | ﹤0.01% | 2358 |
|
|
2025
Q2 | $297K | Sell |
24,180
-1,817
| -7% | -$26.4K | ﹤0.01% | 2413 |
|
|
2025
Q1 | $572K | Buy |
25,997
+7,044
| +37% | +$166K | ﹤0.01% | 2101 |
|
|
2024
Q4 | $430K | Sell |
18,953
-4,448
| -19% | -$97.1K | ﹤0.01% | 2236 |
|
|
2024
Q3 | $425K | Sell |
23,401
-108,102
| -82% | -$2.51M | ﹤0.01% | 2235 |
|
|
2024
Q2 | $3.83M | Buy |
131,503
+106,967
| +436% | +$3.17M | 0.01% | 1339 |
|
|
2024
Q1 | $870K | Sell |
24,536
-2,770
| -10% | -$111K | ﹤0.01% | 1931 |
|
|
2023
Q4 | $1.19M | Buy |
27,306
+1,621
| +6% | +$63.8K | ﹤0.01% | 1817 |
|
|
2023
Q3 | $981K | Sell |
25,685
-62,085
| -71% | -$2.61M | ﹤0.01% | 1888 |
|
|
2023
Q2 | $3.61M | Sell |
87,770
-36,161
| -29% | -$1.74M | 0.01% | 1357 |
|
|
2023
Q1 | $7.11M | Buy |
123,931
+6,753
| +6% | +$381K | 0.01% | 1020 |
|
|
2022
Q4 | $6.57M | Buy |
117,178
+10,439
| +10% | +$531K | 0.01% | 921 |
|
|
2022
Q3 | $4.52M | Buy |
106,739
+6,500
| +6% | +$333K | 0.01% | 1143 |
|
|
2022
Q2 | $5.38M | Sell |
100,239
-172
| -0.2% | -$10.3K | 0.01% | 1056 |
|
|
2022
Q1 | $6.46M | Sell |
100,411
-9,769
| -9% | -$643K | 0.01% | 974 |
|
|
2021
Q4 | $7.43M | Sell |
110,180
-4,407
| -4% | -$298K | 0.01% | 936 |
|
|
2021
Q3 | $7.89M | Sell |
114,587
-27,925
| -20% | -$1.97M | 0.02% | 864 |
|
|
2021
Q2 | $9.73M | Sell |
142,512
-17
| -0% | -$1.2K | 0.02% | 747 |
|
|
2021
Q1 | $9.83M | Sell |
142,529
-2,777
| -2% | -$188K | 0.02% | 682 |
|
|
2020
Q4 | $9.43M | Buy |
145,306
+5,427
| +4% | +$292K | 0.02% | 661 |
|
|
2020
Q3 | $6.62M | Sell |
139,879
-2,281
| -2% | -$109K | 0.02% | 736 |
|
|
2020
Q2 | $6.7M | Buy |
142,160
+34,001
| +31% | +$1.67M | 0.02% | 727 |
|
|
2020
Q1 | $4.81M | Sell |
108,159
-23,968
| -18% | -$1.26M | 0.02% | 780 |
|
|
2019
Q4 | $7.7M | Sell |
132,127
-47,853
| -27% | -$2.85M | 0.02% | 695 |
|
|
2019
Q3 | $10.8M | Buy |
179,980
+11,683
| +7% | +$696K | 0.03% | 570 |
|
|
2019
Q2 | $9.4M | Buy |
168,297
+20,663
| +14% | +$1.06M | 0.03% | 608 |
|
|
2019
Q1 | $8.23M | Sell |
147,634
-432
| -0.3% | -$22K | 0.03% | 643 |
|
|
2018
Q4 | $9.63M | Buy |
148,066
+984
| +0.7% | +$54K | 0.03% | 572 |
|
|
2018
Q3 | $9.72M | Sell |
147,082
-32,674
| -18% | -$2.03M | 0.04% | 540 |
|
|
2018
Q2 | $11.6M | Buy |
179,756
+19,377
| +12% | +$1.2M | 0.04% | 501 |
|
|
2018
Q1 | $8.88M | Sell |
160,379
-23,865
| -13% | -$1.25M | 0.03% | 565 |
|
|
2017
Q4 | $8.82M | Buy |
184,244
+6,719
| +4% | +$329K | 0.03% | 660 |
|
|
2017
Q3 | $8.96M | Buy |
177,525
+40,369
| +29% | +$2.07M | 0.03% | 632 |
|
|
2017
Q2 | $7.48M | Buy |
137,156
+4,455
| +3% | +$213K | 0.03% | 668 |
|
|
2017
Q1 | $5.59M | Buy |
132,701
+35,887
| +37% | +$1.53M | 0.02% | 747 |
|
|
2016
Q4 | $4.15M | Buy |
96,814
+22,224
| +30% | +$903K | 0.02% | 854 |
|
|
2016
Q3 | $3.08M | Buy |
74,590
+21,972
| +42% | +$920K | 0.02% | 908 |
|
|
2016
Q2 | $2.1M | Buy |
52,618
+29,258
| +125% | +$1.05M | 0.01% | 982 |
|
|
2016
Q1 | $787K | Sell |
23,360
-126,644
| -84% | -$3.94M | ﹤0.01% | 1205 |
|
|
2015
Q4 | $5.08M | Buy |
150,004
+54,694
| +57% | +$1.71M | 0.03% | 648 |
|
|
2015
Q3 | $2.84M | Sell |
95,310
-21,044
| -18% | -$658K | 0.03% | 648 |
|
|
2015
Q2 | $3.2M | Buy |
116,354
+68
| +0.1% | +$1.81K | 0.03% | 593 |
|
|
2015
Q1 | $2.93M | Sell |
116,286
-3,821
| -3% | -$90.3K | 0.03% | 612 |
|
|
2014
Q4 | $2.66M | Buy |
+120,107
| New | +$2.44M | 0.02% | 602 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
SEI Investments's IART Position: Q1 2026 in Review
SEI Investments increased its Integra LifeSciences (IART) stake by 58% in Q1 2026, buying an estimated $379K and bringing the position to 93,726 shares worth $883K. The position accounts for ﹤0.01% of the portfolio, ranked #2409.
SEI Investments first reported a position in IART in Q4 2014 and has held it in 46 quarters since. The position peaked at $11.6M in Q2 2018. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- SEI Investments held 93,726 shares of Integra LifeSciences worth $883K as of Q1 2026.
- SEI Investments bought 34,540 Integra LifeSciences shares in Q1 2026, an estimated $379K.
- Integra LifeSciences made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2409 holding.
- SEI Investments first reported a position in Integra LifeSciences in Q4 2014 and has held it in 46 quarters since.
- SEI Investments's Integra LifeSciences position peaked at $11.6M in Q2 2018.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.